DK2316454T3 - Doseringsform indeholdende pantoprazol som aktiv bestanddel - Google Patents

Doseringsform indeholdende pantoprazol som aktiv bestanddel

Info

Publication number
DK2316454T3
DK2316454T3 DK10175417.4T DK10175417T DK2316454T3 DK 2316454 T3 DK2316454 T3 DK 2316454T3 DK 10175417 T DK10175417 T DK 10175417T DK 2316454 T3 DK2316454 T3 DK 2316454T3
Authority
DK
Denmark
Prior art keywords
active ingredient
dosage form
form containing
containing pantoprazole
pantoprazole
Prior art date
Application number
DK10175417.4T
Other languages
English (en)
Inventor
Rango Dietrich
Marc Schiller
Hartmut Ney
Manfred Hartmann
Isabel Anstett-Klein
Sabine Schaefer-Preuss
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33436112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2316454(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of DK2316454T3 publication Critical patent/DK2316454T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK10175417.4T 2003-05-08 2004-05-07 Doseringsform indeholdende pantoprazol som aktiv bestanddel DK2316454T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03010328 2003-05-08
EP04001754 2004-01-28
EP04741525A EP1624869B1 (en) 2003-05-08 2004-05-07 Dosage form containing pantoprazole as active ingredient

Publications (1)

Publication Number Publication Date
DK2316454T3 true DK2316454T3 (da) 2013-01-21

Family

ID=33436112

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04741525.2T DK1624869T3 (da) 2003-05-08 2004-05-07 Doseringsform indeholdende pantoprazol som aktiv bestanddel
DK10175417.4T DK2316454T3 (da) 2003-05-08 2004-05-07 Doseringsform indeholdende pantoprazol som aktiv bestanddel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK04741525.2T DK1624869T3 (da) 2003-05-08 2004-05-07 Doseringsform indeholdende pantoprazol som aktiv bestanddel

Country Status (27)

Country Link
US (2) US20060240100A1 (da)
EP (2) EP2316454B9 (da)
JP (2) JP4878284B2 (da)
KR (2) KR20110104124A (da)
AR (1) AR044264A1 (da)
AU (2) AU2004237363B2 (da)
BR (2) BRPI0410044B8 (da)
CA (1) CA2489140C (da)
CL (1) CL2004000983A1 (da)
CY (2) CY1113128T1 (da)
DK (2) DK1624869T3 (da)
EA (2) EA016824B1 (da)
ES (2) ES2396197T3 (da)
HK (1) HK1090546A1 (da)
HR (2) HRP20120754T1 (da)
IL (2) IL171365A (da)
MX (1) MXPA05000411A (da)
NO (1) NO337921B1 (da)
NZ (1) NZ543181A (da)
PE (1) PE20050199A1 (da)
PL (2) PL1624869T3 (da)
PT (2) PT1624869E (da)
RS (1) RS53443B (da)
SI (2) SI2316454T1 (da)
TW (1) TW200509992A (da)
WO (1) WO2004098594A2 (da)
ZA (1) ZA200508202B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
RS52233B (en) 2004-05-07 2012-10-31 Nycomed Gmbh THE PHARMACEUTICAL DOSAGE FORM CONTAINING GRANULES AND ITS PRODUCTION PROCEDURE
CA2608444A1 (en) * 2005-05-13 2007-03-15 Combino Pharm, S.L. Formulations containing pantoprazole free acid and its salts
EP1747776A1 (en) * 2005-07-29 2007-01-31 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising granular pantoprazole
TWI519322B (zh) * 2008-04-15 2016-02-01 愛戴爾製藥股份有限公司 包含弱鹼性藥物及控制釋放劑型之組合物
WO2010018593A2 (en) * 2008-07-03 2010-02-18 Torrent Pharmaceuticals Ltd. Gastric acid resistant benzimidazole multiple unit tablet composition
BR112013000978A2 (pt) * 2010-07-22 2017-07-11 Lupin Ltd composição de tablete de unidade múltipla
KR101787481B1 (ko) 2010-10-21 2017-10-18 롯데정밀화학 주식회사 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
ITMI20111168A1 (it) * 2011-06-27 2012-12-28 Professional Dietetics Srl Composizioni farmaceutiche comprendenti idrossipropilmetilcellulosa e/o acido ialuronico e loro uso
WO2014016754A2 (en) * 2012-07-26 2014-01-30 Lupin Limited Pharmaceutical compositions of proton pump inhibitor
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
IN201611034271A (de) * 2016-10-06 2018-04-13 Delayed Release Pharmaceutical Composition Of Pantoprazole And Process For Preparation Thereof
WO2023214016A1 (en) * 2022-05-06 2023-11-09 Evonik Operations Gmbh Dosage form with drug release at ph 3 to 6 using double coating system with at least one release acceleration agent

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
IL85472A (en) 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
JPH0768125B2 (ja) 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
DE3901151A1 (de) 1989-01-17 1990-07-19 Hoechst Ag Stabile pharmazeutische zubereitungen von thienoimidazol-derivaten und deren orale anwendung als magensaeuresekretionshemmer
US5183662A (en) 1990-08-30 1993-02-02 Senju Pharmaceutical Co., Ltd. Controlled drug release composition
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
ATE157864T1 (de) * 1991-12-18 1997-09-15 Warner Lambert Co Verfahren für die herstellung einer festen dispersion
EP0695123A4 (en) * 1993-04-27 1996-09-11 Sepracor Inc METHOD AND COMPOSITIONS FOR TREATING GASTRICAL FAULTS USING OPTICALLY PURE PANTOPRAZOLS
DK0723436T3 (da) 1994-07-08 2001-11-26 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US5945124A (en) 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE508669C2 (sv) 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
JP3249914B2 (ja) 1996-06-04 2002-01-28 清水食品株式会社 成型用焼結金型およびその形成方法
US6072024A (en) 1997-03-21 2000-06-06 Mitsui Chemicals, Inc. Production process of cross-linked polyaspartic acid resin
AU1671799A (en) * 1997-11-28 1999-06-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Medicament preparation in the form of a tablet or pellet for acid-labile active substances
ATE260090T1 (de) 1997-12-08 2004-03-15 Altana Pharma Ag Neue suppositoriumsform mit säureempfindliche wirkstoffe
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
CU23051A3 (es) * 1998-05-15 2005-06-24 Warner Lambert Co Composiciones solidas que contienen derivados de acido gamma-aminobutirico y procesos para prepararlas.
ZA9810765B (en) * 1998-05-28 1999-08-06 Ranbaxy Lab Ltd Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
JP3274416B2 (ja) * 1998-05-29 2002-04-15 佐藤製薬株式会社 口腔内崩壊性粒状製剤
ES2262335T3 (es) 1998-08-12 2006-11-16 Altana Pharma Ag Forma de administracion oral para piridin-2-ilmetilsulfinil-1h-bencimidazoles.
DE19843413C1 (de) 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
YU86001A (sh) 1999-06-07 2004-07-15 Altana Pharma Ag. Novi preparat i oblik, u kojem se daje lek, koji sadrži aktivno jedinjenje labilno prema kiselini
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
US6346269B1 (en) * 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
SI20720A (sl) * 2000-11-20 2002-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov farmacevtski pripravek v obliki celuloznih kapsul uporaben za derivate benzimidazola
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
WO2002045694A1 (en) 2000-12-07 2002-06-13 Altana Pharma Ag Rapidly disintegrating tablet comprising an acid-labile active ingredient
WO2002045692A1 (en) * 2000-12-07 2002-06-13 Altana Pharma Ag Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
RS52233B (en) 2004-05-07 2012-10-31 Nycomed Gmbh THE PHARMACEUTICAL DOSAGE FORM CONTAINING GRANULES AND ITS PRODUCTION PROCEDURE
JP4563077B2 (ja) 2004-05-28 2010-10-13 株式会社ロッテ キャンディ及びその製造方法

Also Published As

Publication number Publication date
AU2004237363A1 (en) 2004-11-18
RS53443B (en) 2014-12-31
EP1624869B1 (en) 2012-07-04
JP4878284B2 (ja) 2012-02-15
IL171365A (en) 2014-08-31
EP1624869A2 (en) 2006-02-15
CY1113462T1 (el) 2016-06-22
NO337921B1 (no) 2016-07-11
BR122016006880B1 (pt) 2020-11-10
NZ543181A (en) 2009-10-30
EP2316454A1 (en) 2011-05-04
PL1624869T3 (pl) 2012-11-30
AR044264A1 (es) 2005-09-07
JP2011126912A (ja) 2011-06-30
HRP20120754T1 (hr) 2012-11-30
EP2316454B9 (en) 2013-01-02
IL229510A (en) 2016-09-29
BRPI0410044B8 (pt) 2021-05-25
KR101237742B1 (ko) 2013-02-26
EP2316454B1 (en) 2012-09-26
NO20055631L (no) 2005-11-29
BRPI0410044A (pt) 2006-04-25
KR20110104124A (ko) 2011-09-21
JP5162689B2 (ja) 2013-03-13
CL2004000983A1 (es) 2005-03-04
IL229510A0 (en) 2013-12-31
US20060240100A1 (en) 2006-10-26
CY1113128T1 (el) 2016-04-13
HRP20121005T1 (hr) 2013-01-31
US8703192B2 (en) 2014-04-22
MXPA05000411A (es) 2005-03-23
WO2004098594A3 (en) 2004-12-09
PT2316454E (pt) 2012-12-06
TW200509992A (en) 2005-03-16
SI2316454T1 (sl) 2013-01-31
ES2396197T3 (es) 2013-02-19
CA2489140C (en) 2006-10-17
PL2316454T3 (pl) 2013-03-29
CA2489140A1 (en) 2004-11-18
WO2004098594A2 (en) 2004-11-18
EA200501697A1 (ru) 2006-06-30
RS20050818A (en) 2008-04-04
KR20060010774A (ko) 2006-02-02
EA027734B1 (ru) 2017-08-31
AU2004237363B2 (en) 2009-12-10
JP2006525286A (ja) 2006-11-09
AU2010200905A1 (en) 2010-04-01
EA016824B1 (ru) 2012-07-30
ES2390342T3 (es) 2012-11-12
ZA200508202B (en) 2006-12-27
US20090208571A1 (en) 2009-08-20
SI1624869T1 (sl) 2012-10-30
AU2010200905B2 (en) 2012-04-05
PT1624869E (pt) 2012-09-18
PE20050199A1 (es) 2005-03-26
DK1624869T3 (da) 2012-10-01
HK1090546A1 (en) 2006-12-29
EA201101119A1 (ru) 2011-12-30
BRPI0410044B1 (pt) 2019-05-07
BR122016006880B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
IL229510A0 (en) A dosage form containing pantoprazole as an active ingredient
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
DK1498411T3 (da) Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
FR15C0095I2 (fr) Combinaisons synergiques de substances actives fongicides
DK1864665T3 (da) Immunsuppressivt middel indeholdende en heterocyklisk forbindelse som aktiv bestanddel
NO20055143D0 (no) Doseringsformer innbefattende AG013736
DE60317967D1 (de) Umhüllte feste Darreichungsform
DK1592457T3 (da) Folat-vinblastin-konjugat som lægemiddel
NO20050426L (no) Arylkarbonylderivater som terapeutiske midler
DK1615646T4 (da) Farmaceutiske formuleringer, der indeholder methylnaltrexon
NO20052739D0 (no) CCR5-antagonister som medikamenter
ATE460169T1 (de) Pharmazeutische formulierung mit lanthanum- verbindungen
EP1631239A4 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE COMPOUNDS OF VITAMIN D
PT1501534E (pt) Formulacoes farmaceuticas
DK1608362T3 (da) Stabiliseret farmaceutisk præparat indeholdende en amorf aktiv forbindelse
DK1557415T3 (da) Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
DK1932522T3 (da) Terapeutisk middel mod leversygdom indeholdende 2-amino-1,3-propandiolderivat som aktiv bestanddel
NO20054214D0 (no) Iminoeterderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
MA28527B1 (fr) Formulations orales contenant licarbazepine
ATE369139T1 (de) Hochdosierte ibandronat-formulierung
FI20041129A0 (fi) Tioksotiatsolidinoniyhdisteitä lääkkeinä käytettäviksi
DK1494650T3 (da) Farmaceutisk formulering, der indeholder melatonin
DK1666473T3 (da) Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens